Extended clopidogrel monotherapy vs DAPT in patients with acute coronary syndromes at high ischemic and bleeding risk: the OPT-BIRISK randomized clinical trial - Li, Y; Li, J; Wang, B; OPT-BIRISK Investigators (JAMA Cardiol, 2024)